“ANTITUMOR EFFECT OF SUNITINIB AND BORTEZOMIB ON BREAST CANCER CELL LINE IN VITRO”. Voprosy Onkologii, vol. 63, no. 1, Jan. 2017, pp. 141-5, https://doi.org/10.37469/0507-3758-2017-63-1-141-145.